GD-2 CAR T cells (EBV-specific CTLs expressing GD-2 CAR)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GD-2 CAR T cells (EBV-specific CTLs expressing GD-2 CAR), covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients [Phase 1]